MarketPeel
Insider Trading Intelligence
BJ

Bahija Jallal

ELV
DIRECTOR · ELEVANCE HEALTH, INC. · CIK 0001730038
FILING MIX · LIFETIME84%/16%
BUYS
16
SELLS
3
TOTAL VALUE
$371.2K
COMPANIES
4
ACTIVE SINCE
Jun 2020
HOLDINGS NOW
35,578
AVG SELL PX
$32.35
TRADE KIND
SHOWING 19 / 19
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Bahija Jallal, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-1.08%+1.00%-2.08%-2.08%
14d1+0.00%+3.75%-0.17%+3.92%+3.92%
30d1+100.00%-8.00%-5.50%-2.50%-2.50%
60d1+100.00%-3.23%+3.27%-6.50%-6.50%
90d1+100.00%-11.01%+8.16%-19.18%-19.18%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ELV · 5,351 shares · as of May 13, 2026
01,3382,6764,0135,351202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 16 buys / 3 sellsCOVERAGE · 25 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
5635,351May 13, 2026May 15, 2026View →
IMCR
IMMUNOCORE HOLDINGS PLC
SALE
CHIEF EXECUTIVE OFFICER
11,474$32.35$371.2K12,343Feb 18, 2026Feb 19, 2026View →
IMCR
IMMUNOCORE HOLDINGS PLC
PURCHASEGRANT
Stock grant
88,57388,573Feb 17, 2026Feb 19, 2026View →
IMCR
IMMUNOCORE HOLDINGS PLC
PURCHASEGRANT
Stock grant
395,066395,066Feb 17, 2026Feb 19, 2026View →
IMCR
IMMUNOCORE HOLDINGS PLC
SALE
CHIEF EXECUTIVE OFFICER
23,81771,453Feb 17, 2026Feb 19, 2026View →
IMCR
IMMUNOCORE HOLDINGS PLC
PURCHASE
CHIEF EXECUTIVE OFFICER
23,81723,817Feb 17, 2026Feb 19, 2026View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
6014,788May 14, 2025May 16, 2025View →
IMCR
IMMUNOCORE HOLDINGS PLC
PURCHASEGRANT
Stock grant
95,27095,270Feb 17, 2025Feb 19, 2025View →
IMCR
IMMUNOCORE HOLDINGS PLC
PURCHASEGRANT
Stock grant
405,824405,824Feb 17, 2025Feb 19, 2025View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
3884,187May 15, 2024May 17, 2024View →
IMCR
IMMUNOCORE HOLDINGS PLC
PURCHASEGRANT
Stock grant
281,819281,819Feb 16, 2024Feb 21, 2024View →
AVBP
ARRIVENT BIOPHARMA, INC.
PURCHASEGRANT
Stock grant
17,88417,884Jan 25, 2024Jan 29, 2024View →
ELV
ELEVANCE HEALTH, INC.
PURCHASEGRANT
Stock grant
4573,799May 10, 2023May 12, 2023View →
GH
GUARDANT HEALTH, INC.
PURCHASE
1,8147,408Jun 15, 2022Jun 17, 2022View →
GH
GUARDANT HEALTH, INC.
SALE
1,8140Jun 15, 2022Jun 17, 2022View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
3,1353,135Jun 16, 2021Jun 21, 2021View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
1,8141,814Jun 16, 2021Jun 21, 2021View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
2,7575,594Jun 12, 2020Jun 16, 2020View →
GH
GUARDANT HEALTH, INC.
PURCHASEGRANT
Stock grant
4,8404,840Jun 12, 2020Jun 16, 2020View →
Other insiders · ELV
Loading peer insiders…
About this filer
CIK 0001730038
ROLE
Director
PRIMARY
ELV
COMPANIES
4
ACTIVE SINCE
Jun 2020
MARKETPEEL · /INSIDER/0001730038DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback